相关实验视频
Updated: Jul 20, 2025
07:17
Author Spotlight: Exploring Abdominal VNS for Inflammatory Conditions
Published on: January 19, 2024
1.9K
慢性迷走神经刺激心力衰竭患者:挑战或失败的翻译?
Zhihong Wu1, Jiaying Liao2, Qiming Liu1
1Department of Cardiovascular, The Second Xiangya Hospital of Central South University, Changsha, China.
Frontiers in cardiovascular medicine
|August 3, 2023
概括
自主神经系统的不平衡会使心力衰竭 (HF) 恶化. 迷走神经刺激 (VNS) 在临床前HF模型中表现有前途,但临床试验结果相矛盾,需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 神经科学是一个神经科学.
- 医疗技术 医疗技术 医学技术
背景情况:
- 自主神经系统的不平衡,特别是交感性过度活动和副交感性戒断,是慢性心力衰竭 (HF) 进展的关键因素.
- 临床前研究表明,神经调节,包括迷走神经刺激 (VNS),在实验性HF模型中提供心脏保护性益处.
研究的目的:
- 审查自主神经系统在心力衰竭病理生理学中的作用.
- 批判性地评估迷走神经刺激 (VNS) 作为心力衰竭治疗策略的有效性.
- 探索临床前发现和临床试验结果之间的差异的潜在原因在HF中VNS.
主要方法:
- 关于神经调节和HF的临床前研究的文献评论.
- 对临床试验数据的分析,研究心力衰竭患者的迷走神经刺激 (VNS).
- 综合证据,以确定导致结果矛盾的因素.
主要成果:
- 临床前数据强烈支持VNS在心力衰竭模型中的心脏保护作用.
- 心力衰竭患者的临床试验对VNS疗效产生了不一致和矛盾的结果.
- 这种差异凸显了将临床前发现转化为临床实践的挑战.
结论:
- 自主神经系统在心力衰竭中起着至关重要的作用.
- 迷走神经刺激 (VNS) 在心力衰竭治疗方面具有理论上的前景,但临床证据仍然不确.
- 需要进一步的研究来协调临床前和临床发现,并优化心力衰竭的VNS治疗.
更多相关视频
相关概念视频
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:26Heart Failure Drugs: Inotropic Agents
625
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
625
01:29Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
01:27Heart Failure I: Introduction
16
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16
01:26Heart Failure III: Clinical Manifestations
23
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23